FR75178E
(ja)
*
|
1956-12-20 |
1961-09-08 |
|
|
US5763596A
(en)
*
|
1989-09-15 |
1998-06-09 |
Metabasis Therapeutics, Inc. |
C-4' modified adenosine kinase inhibitors
|
WO1994018215A1
(en)
*
|
1993-02-03 |
1994-08-18 |
Gensia, Inc. |
Adenosine kinase inhibitors comprising lyxofuranosyl derivatives
|
US5514798A
(en)
*
|
1993-06-02 |
1996-05-07 |
Gilead Sciences, Inc. |
Method and cyclic carbonates for nucleotide analogues
|
EP0879056B1
(en)
|
1996-01-23 |
2002-05-02 |
ICN Pharmaceuticals, Inc. |
Modulation of th1/th2 cytokine expression by ribavirin in activated t-lymphocytes
|
US6128582A
(en)
|
1996-04-30 |
2000-10-03 |
Vertex Pharmaceuticals Incorporated |
Molecules comprising an IMPDH-like binding pocket and encoded data storage medium capable of graphically displaying them
|
JP2002503212A
(ja)
|
1996-10-16 |
2002-01-29 |
アイ・シー・エヌ・フアーマシユーテイカルズ・インコーポレイテツド |
単環式ヌクレオシド、その類似体および使用
|
CN1233254A
(zh)
|
1996-10-16 |
1999-10-27 |
Icn药品公司 |
嘌呤l-核苷、其类似物及其用途
|
GB9623908D0
(en)
|
1996-11-18 |
1997-01-08 |
Hoffmann La Roche |
Amino acid derivatives
|
SK64399A3
(en)
|
1996-11-19 |
2000-05-16 |
Icn Pharmaceuticals |
Multivalent salts of pyridostigmine and related compounds
|
EP0968226A4
(en)
|
1996-12-27 |
2001-02-14 |
Icn Pharmaceuticals |
OLIGOAPTAMERS WITH G-ENRICHED REGIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE
|
PL336579A1
(en)
|
1997-01-17 |
2000-07-03 |
Icn Pharmaceuticals |
Treatment of diseases associated with cytokinins
|
SE9700792L
(sv)
|
1997-03-06 |
1998-02-23 |
Carlo Castro |
Ryggsmörjare för insmörjning av hudkräm på en människokropp
|
GB9707659D0
(en)
|
1997-04-16 |
1997-06-04 |
Peptide Therapeutics Ltd |
Hepatitis C NS3 Protease inhibitors
|
EP1000075A4
(en)
|
1997-06-30 |
2001-09-05 |
Icn Pharmaceuticals |
PROCESS FOR PRODUCING TIAZOFURINE AND OTHER C-NUCLEOSIDES
|
IL121413A
(en)
|
1997-07-28 |
2000-10-31 |
Green Cloud Ltd |
Method for reducing the accumulation of precipitates and impurities on ultrasonic transducers
|
ATE291032T1
(de)
|
1997-08-11 |
2005-04-15 |
Boehringer Ingelheim Ca Ltd |
Hepatitis c inhibitor peptide
|
CA2294562C
(en)
|
1997-08-11 |
2005-07-26 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis c inhibitor peptide analogues
|
AU2212699A
(en)
|
1998-01-15 |
1999-08-02 |
Icn Pharmaceuticals, Inc. |
Use of 8-cl-camp in prevention of restenosis of arterial walls
|
EA200700564A1
(ru)
|
1998-02-25 |
2007-08-31 |
Эмори Юниверсити |
2`-фторнуклеозиды
|
JP4741725B2
(ja)
*
|
1998-03-06 |
2011-08-10 |
メタベイシス・セラピューティクス・インコーポレーテッド |
リン含有化合物のための新規なプロドラッグ
|
US6312662B1
(en)
*
|
1998-03-06 |
2001-11-06 |
Metabasis Therapeutics, Inc. |
Prodrugs phosphorus-containing compounds
|
GB9806815D0
(en)
|
1998-03-30 |
1998-05-27 |
Hoffmann La Roche |
Amino acid derivatives
|
AU3376699A
(en)
|
1998-03-31 |
1999-10-18 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease
|
UA61997C2
(en)
|
1998-05-26 |
2003-12-15 |
Icn Pharmaceuticals |
Nucleosides with bicyclic sugar constituent, oligonucleotide and antiviral pharmaceutical composition
|
GB9812523D0
(en)
|
1998-06-10 |
1998-08-05 |
Angeletti P Ist Richerche Bio |
Peptide inhibitors of hepatitis c virus ns3 protease
|
US6323180B1
(en)
|
1998-08-10 |
2001-11-27 |
Boehringer Ingelheim (Canada) Ltd |
Hepatitis C inhibitor tri-peptides
|
US6045638A
(en)
|
1998-10-09 |
2000-04-04 |
Atlantic Research Corporation |
Monopropellant and propellant compositions including mono and polyaminoguanidine dinitrate
|
JP2002528499A
(ja)
|
1998-10-29 |
2002-09-03 |
ブリストル−マイヤーズ スクイブ カンパニー |
Impdh酵素のインヒビターであるアミノ核誘導化合物
|
CN1334736A
(zh)
|
1999-01-29 |
2002-02-06 |
Icn药品公司 |
病毒唑对免疫反应的调节作用
|
UA74546C2
(en)
|
1999-04-06 |
2006-01-16 |
Boehringer Ingelheim Ca Ltd |
Macrocyclic peptides having activity relative to hepatitis c virus, a pharmaceutical composition and use of the pharmaceutical composition
|
WO2001000622A1
(en)
|
1999-06-25 |
2001-01-04 |
Vertex Pharmaceuticals Incorporated |
Prodrugs of carbamate inhibitors of impdh
|
MXPA02001753A
(es)
|
1999-08-27 |
2002-10-23 |
Ribapharm Inc |
Analogos de nucleosido de pirrolo [2,3-d]pirimidina.
|
US6752981B1
(en)
*
|
1999-09-08 |
2004-06-22 |
Metabasis Therapeutics, Inc. |
Prodrugs for liver specific drug delivery
|
US6518253B1
(en)
|
1999-11-19 |
2003-02-11 |
Robert Tam |
Treatment of viral infections using the L-isomer of ribavirin
|
WO2001045642A2
(en)
|
1999-12-13 |
2001-06-28 |
Icn Pharmaceuticals, Inc. |
Pulmonary delivery of ribavirin or levovirin™ for systemic and quasi-systemic treatment of disease
|
CN1420723A
(zh)
|
1999-12-23 |
2003-05-28 |
Icn药品公司 |
L-核苷、l-核苷酸及其类似物的组合物和方法
|
ID30204A
(id)
|
1999-12-27 |
2001-11-15 |
Japan Tobacco Inc |
Senyawa-senyawa cincin terfusi dan penggunaannya sebagai obat
|
US6455508B1
(en)
|
2000-02-15 |
2002-09-24 |
Kanda S. Ramasamy |
Methods for treating diseases with tirazole and pyrrolo-pyrimidine ribofuranosyl nucleosides
|
US6495677B1
(en)
|
2000-02-15 |
2002-12-17 |
Kanda S. Ramasamy |
Nucleoside compounds
|
US6727267B2
(en)
|
2000-04-05 |
2004-04-27 |
Tularik Inc. |
NS5B HVC polymerase inhibitors
|
ATE414520T1
(de)
|
2000-04-13 |
2008-12-15 |
Pharmasset Inc |
3 oder 2 hydroxymethyl substituierte nucleoside derivate und ihre verwendung zur behandlung von virusinfektionen
|
MY164523A
(en)
*
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
CA2410579C
(en)
*
|
2000-05-26 |
2010-04-20 |
Jean-Pierre Sommadossi |
Methods and compositions for treating flaviviruses and pestiviruses
|
US6448281B1
(en)
|
2000-07-06 |
2002-09-10 |
Boehringer Ingelheim (Canada) Ltd. |
Viral polymerase inhibitors
|
UA72612C2
(en)
|
2000-07-06 |
2005-03-15 |
|
Pyrido[2.3-d]pyrimidine and pyrimido[4.5-d]pyrimidine nucleoside analogues, prodrugs and method for inhibiting growth of neoplastic cells
|
GB0017676D0
(en)
|
2000-07-19 |
2000-09-06 |
Angeletti P Ist Richerche Bio |
Inhibitors of viral polymerase
|
JP2004506684A
(ja)
|
2000-08-22 |
2004-03-04 |
リバフアーム・インコーポレーテツド |
肝細胞への薬物送達及びフラビウイルス感染症の治療の方法
|
CN1460109A
(zh)
|
2000-08-22 |
2003-12-03 |
里巴药品公司 |
改善疾病治疗的特异性
|
US20030008841A1
(en)
|
2000-08-30 |
2003-01-09 |
Rene Devos |
Anti-HCV nucleoside derivatives
|
US6809101B2
(en)
|
2000-09-01 |
2004-10-26 |
Shionogi & Co., Ltd. |
Compounds having anti-hepatitis C virus effect
|
KR101005299B1
(ko)
|
2000-10-18 |
2011-01-04 |
파마셋 인코포레이티드 |
바이러스 감염 및 비정상적인 세포 증식의 치료를 위한 변형된 뉴클레오시드
|
IL155842A0
(en)
|
2000-12-12 |
2003-12-23 |
Schering Corp |
Diaryl peptides as ns3-serine protease inhibitors of hepatitis c virus
|
AU2002230763A1
(en)
|
2000-12-13 |
2008-01-03 |
Bristol-Myers Squibb Pharma Company |
Inhibitors of hepatitis c virus ns3 protease
|
JP2005502580A
(ja)
|
2000-12-15 |
2005-01-27 |
フアーマセツト・リミテツド |
フラビウィルス感染治療用抗ウィルス薬
|
CN1482914A
(zh)
|
2000-12-26 |
2004-03-17 |
三菱制药株式会社 |
丙型肝炎治疗剂
|
HUP0400726A3
(en)
|
2001-01-22 |
2007-05-29 |
Merck & Co Inc |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
GB0114286D0
(en)
|
2001-06-12 |
2001-08-01 |
Hoffmann La Roche |
Nucleoside Derivatives
|
WO2002102307A2
(en)
|
2001-06-15 |
2002-12-27 |
Ribapharm |
Nucleoside vaccine adjuvants
|
GB2378524A
(en)
|
2001-08-08 |
2003-02-12 |
Bookham Technology Plc |
Intergrated optic device
|
GB0119369D0
(en)
|
2001-08-08 |
2001-10-03 |
Bookham Technology Plc |
Optic system
|
EP1438054A4
(en)
|
2001-09-28 |
2006-07-26 |
Idenix Cayman Ltd |
METHODS AND COMPOSITIONS FOR TREATING FLAVIVIRUS AND PESTIVIRUS USING MODIFIED NUCLEOSIDE AT 4 'POSITION
|
WO2003026589A2
(en)
|
2001-09-28 |
2003-04-03 |
Idenix (Cayman) Limited |
Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides
|
US20030072451A1
(en)
|
2001-10-16 |
2003-04-17 |
Pimentel Roberto J. |
Method and apparatus for securely transferring wireless data
|
WO2003034709A1
(en)
|
2001-10-17 |
2003-04-24 |
Naltec Inc. |
Decompressing method and data processor
|
WO2003037908A1
(en)
|
2001-10-31 |
2003-05-08 |
Ribapharm Inc. |
Antiviral combination therapy and compositions
|
WO2003051898A1
(en)
|
2001-12-17 |
2003-06-26 |
Ribapharm Inc. |
Unusual nucleoside libraries, compounds, and preferred uses as antiviral and anticancer agents
|
AU2002353165A1
(en)
|
2001-12-17 |
2003-06-30 |
Ribapharm Inc. |
Deazapurine nucleoside libraries and compounds
|
AU2002359732A1
(en)
|
2001-12-17 |
2003-06-30 |
Ribapharm Inc. |
Substituted purine nucleoside libraries and compounds by solid-phase combinatorial strategies
|
AU2002357876A1
(en)
|
2001-12-17 |
2003-06-30 |
Ribapharm Inc. |
Nucleoside analog libraries and compounds
|
AU2002349905A1
(en)
|
2001-12-17 |
2003-06-30 |
Ribapharm Inc. |
Nucleoside libraries and compounds by mcc combinatorial strategies on solid support
|
WO2003051896A1
(en)
|
2001-12-17 |
2003-06-26 |
Ribapharm Inc. |
Cytidine libraries and compounds synthesized by solid-phase combinatorial strategies
|
WO2003057287A1
(fr)
|
2001-12-28 |
2003-07-17 |
Terumo Kabushiki Kaisha |
Seringue
|
WO2003062256A1
(en)
|
2002-01-17 |
2003-07-31 |
Ribapharm Inc. |
2'-beta-modified-6-substituted adenosine analogs and their use as antiviral agents
|
WO2003062255A2
(en)
*
|
2002-01-17 |
2003-07-31 |
Ribapharm Inc. |
Sugar modified nucleosides as viral replication inhibitors
|
CA2474563C
(en)
*
|
2002-02-13 |
2010-11-09 |
Merck & Co., Inc. |
Methods of inhibiting orthopoxvirus replication with nucleoside compounds
|
US20040063658A1
(en)
*
|
2002-05-06 |
2004-04-01 |
Roberts Christopher Don |
Nucleoside derivatives for treating hepatitis C virus infection
|
WO2004037161A2
(en)
*
|
2002-05-13 |
2004-05-06 |
Metabasis Therapeutics, Inc. |
Cyclic prodrugs of pmea one of its analogues
|
CA2485597C
(en)
*
|
2002-05-13 |
2013-07-02 |
Metabasis Therapeutics, Inc. |
Process for preparation of cyclic prodrugs of pmea and pmpa
|
EP1572945A2
(en)
*
|
2002-06-27 |
2005-09-14 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
ES2469569T3
(es)
|
2002-06-28 |
2014-06-18 |
Idenix Pharmaceuticals, Inc. |
Prof�rmacos de nucle�sidos modificados en 2' y 3' para el tratamiento de infecciones de Flaviviridae
|
RS113904A
(en)
|
2002-06-28 |
2007-02-05 |
Idenix (Cayman) Limited |
2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
|
MXPA04012779A
(es)
|
2002-06-28 |
2005-08-19 |
Idenix Cayman Ltd |
Profarmacos de 2'- y 3'-nucleosido para tratar infecciones por flaviviridae.
|
EP1556399A4
(en)
*
|
2002-07-16 |
2007-09-26 |
Merck & Co Inc |
NUCLEOSIDE DERIVATIVES AS RNA-DEPENDENT VIRAL RNA POLYMERASE INHIBITORS
|
US8093380B2
(en)
|
2002-08-01 |
2012-01-10 |
Pharmasset, Inc. |
Compounds with the bicyclo[4.2.1]nonane system for the treatment of Flaviviridae infections
|
US7425547B2
(en)
*
|
2002-09-30 |
2008-09-16 |
Genelabs Technologies, Inc. |
Nucleoside derivatives for treating hepatitis C virus infection
|
WO2004041834A2
(en)
*
|
2002-10-31 |
2004-05-21 |
Metabasis Therapeutics, Inc. |
Novel cyclic phosphate diesters of 1,3-propane-1-aryl diols and their use in preparing prodrugs
|
CN1849142A
(zh)
|
2002-11-15 |
2006-10-18 |
埃迪尼克斯(开曼)有限公司 |
2′-支链核苷和黄病毒突变
|
TWI294882B
(en)
*
|
2002-12-09 |
2008-03-21 |
Hoffmann La Roche |
Anhydrous crystalline azido cytosine hemisulfate derivative
|
TW200510425A
(en)
|
2003-08-13 |
2005-03-16 |
Japan Tobacco Inc |
Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor
|
CN102020697B
(zh)
|
2003-10-14 |
2014-10-29 |
F·霍夫曼-罗须公司 |
作为hcv复制抑制剂的巨环羧酸和酰基磺酰胺
|
US7151089B2
(en)
*
|
2003-10-27 |
2006-12-19 |
Genelabs Technologies, Inc. |
Nucleoside compounds for treating viral infections
|
KR20060096487A
(ko)
*
|
2003-10-27 |
2006-09-11 |
진랩스 테크놀러지스, 인크. |
바이러스 감염증들을 치료하기 위한 뉴클레오시드 화합물
|
US20050182252A1
(en)
*
|
2004-02-13 |
2005-08-18 |
Reddy K. R. |
Novel 2'-C-methyl nucleoside derivatives
|